Sarissa Capital Management as of June 30, 2021
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 14 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS (ALKS) | 23.1 | $291M | 12M | 24.52 | |
| Biogen Idec (BIIB) | 17.7 | $223M | 643k | 346.27 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 16.8 | $211M | 16M | 12.87 | |
| Gilead Sciences (GILD) | 14.8 | $186M | 2.7M | 68.86 | |
| Alexion Pharmaceuticals | 9.5 | $120M | 650k | 183.71 | |
| Innoviva (INVA) | 6.8 | $86M | 6.4M | 13.41 | |
| BioCryst Pharmaceuticals (BCRX) | 5.4 | $67M | 4.3M | 15.81 | |
| Mersana Therapeutics (MRSN) | 4.3 | $54M | 4.0M | 13.58 | |
| Vor Biopharma (VOR) | 1.0 | $13M | 707k | 18.65 | |
| Sarissa Capital Acquisitn W Exp 10/23/202 | 0.4 | $5.0M | 3.3M | 1.50 | |
| Regulus Therapeutics Com New | 0.1 | $1.5M | 1.9M | 0.81 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.0 | $177k | 1.0k | 177.00 | |
| Mirati Therapeutics | 0.0 | $161k | 1.0k | 161.00 | |
| Intercept Pharmaceuticals In | 0.0 | $18k | 950.00 | 18.95 |
